Clinical Trials
2 trialsNCT03319628 2023-11-13
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b
Mersana Therapeutics
Phase 1/2 Active not recruiting
NCT01711970 2020-04-24
A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian Cancer
Vascular Biogenics Ltd. operating as VBL Therapeutics
Phase 1/2 Completed